Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 14;15(1):46.
doi: 10.1186/s13104-022-05918-3.

Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis

Affiliations

Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis

Shahrzad Zehtab et al. BMC Res Notes. .

Abstract

Objective: Acute lymphoblastic leukemia (ALL) is one of the most common cancers in children for which the exact pathogenesis is not yet known. Single-nucleotide variants (SNVs) in different DNA repair genes are reported to be associated with ALL risk. This study aimed to determine the association between XRCC1 (rs1799782) and NBN (rs1805794, rs709816) SNVs and childhood ALL risk in a sample of the Iranian population. Fifty children with ALL and 50 age- and sex-matched healthy children were included in this case-control study. Genotyping of the mentioned SNVs was done by high-resolution melting (HRM) analysis.

Results: The prevalence of all three SNVs in XRCC1 and NBN genes did not differ between the patient and control groups, and these polymorphisms were not associated with childhood ALL risk (P > 0.05). HRM was a practical method for the detection of SNVs in XRCC1 and NBN genes. We found no significant association between XRCC1 (rs1799782) and NBN (rs1805794, rs709816) SNVs and childhood ALL risk.

Keywords: Childhood acute lymphoblastic Leukemia; High-resolution melting analysis; NBN; Single nucleotide variants; XRCC1.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Similar articles

Cited by

References

    1. Abo-Bakr A, Mossallam G, El Azhary N, et al. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia. J Egypt Natl Canc Inst. 2017;29:127–133. doi: 10.1016/j.jnci.2017.07.002. - DOI - PubMed
    1. Lymphoid leukemia—an overview | ScienceDirect topics. https://www.sciencedirect.com/topics/medicine-and-dentistry/lymphoid-leu.... Accessed 1 May 2020.
    1. Al-Absi B, Razif MFM, Noor SM, et al. Contributions of IKZF1 DDC, CDKN2A, CEBPE, and LMO1 gene polymorphisms to acute lymphoblastic leukemia in a yemeni population. Genet Test Mol Biomarkers. 2017;21:592–599. doi: 10.1089/gtmb.2017.0084. - DOI - PubMed
    1. Jung SH, Lee SE, Lee M, et al. Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma. Haematologica. 2017;102:e456. - PMC - PubMed
    1. Belson M, Kingsley B, Holmes A. Risk factors for acute leukemia in children: a review. Environ Health Perspect. 2007;115:138–145. doi: 10.1289/ehp.9023. - DOI - PMC - PubMed